World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0000056527
Reproduction Date:

Title: Galactose  
Author: World Heritage Encyclopedia
Language: English
Subject: Fructose, Lactose, Glucose, Carbohydrate, O-linked glycosylation
Collection: Galactose, Nutrition, Sugar Substitutes
Publisher: World Heritage Encyclopedia


CAS number  N
ChemSpider  YesY
ATC code V04,
V08 (microparticles)
Jmol-3D images Image 1
Molecular formula C6H12O6
Molar mass 180.156 g mol−1
Density 1.723 g/cm3
Melting point 167 °C (333 °F; 440 K)
Solubility in water 683.0 g/L
NFPA 704
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
 N   YesY/N?)

Galactose (from the Greek stem γάλακτ– galakt–, "milk"), sometimes abbreviated Gal, is a monosaccharide sugar that is less sweet than glucose and fructose. It is a C-4 epimer of glucose.

Galactan is a polymer of the sugar galactose found in hemicellulose. Galactan can be converted to galactose by hydrolysis.


  • Structure and isomerism 1
  • Relationship to lactose 2
  • Metabolism 3
  • Sources 4
  • Clinical significance 5
  • History 6
  • See also 7
  • References 8

Structure and isomerism

Galactose exists in both open-chain and cyclic form. The open-chain form has a carbonyl at the end of the chain. In the open-chain form D- and L- isomers cannot be separated, but the cyclic forms can be crystallized and isolated.[1]

Four isomers are cyclic, two of them with a pyranose (six-membered) ring, two with a furanose (five-membered) ring. Galactofuranose occurs in bacteria, fungi and protozoa. [2] In the cyclic form there are two anomers, named alpha and beta, since the transition from the open-chain form to the cyclic form involves the creation of a new stereocenter at the site of the open-chain carbonyl. In the beta form, the alcohol group is in the equatorial position, whereas in the alpha form, the alcohol group is in the axial position.[1]

Cyclic forms of galactose

Relationship to lactose

Galactose is a monosaccharide. When combined with glucose (monosaccharide), through a condensation reaction, the result is the disaccharide lactose. The hydrolysis of lactose to glucose and galactose is catalyzed by the enzymes lactase and β-galactosidase. The latter is produced by the lac operon in Escherichia coli.

In nature, lactose is found primarily in milk and milk products. Consequently, various food products made with dairy-derived ingredients, e.g. breads and cereals, can contain lactose.[3] Galactose metabolism, which converts galactose into glucose, is carried out by the three principal enzymes in a mechanism known as the Leloir pathway. The enzymes are listed in the order of the metabolic pathway: galactokinase (GALK), galactose-1-phosphate uridyltransferase (GALT), and UDP-galactose-4’-epimerase (GALE).

In the human body, glucose is changed into galactose via hexoneogenesis to enable the mammary glands to secrete lactose. However, most lactose in breast milk is synthesized from galactose taken up from the blood, and only 35±6% is made from galactose from de novo synthesis. [4] Glycerol also contributes some to the mammary galactose production.[5]


Galactose metabolism

Glucose is the primary metabolic fuel for humans. It is more stable than galactose and is less susceptible to the formation of nonspecific glycoconjugates, molecules with at least one sugar attached to a protein or lipid. Many speculate that it is for this reason that a pathway for rapid conversion from galactose to glucose has been highly conserved among many species.[6]

The main pathway of galactose metabolism is the Leloir pathway; humans and other species, however, have been noted to contain several alternate pathways, such as the De Ley Doudoroff pathway. The Leloir pathway consists of the latter stage of a two-part process that converts β-D-galactose to UDP-glucose. The initial stage is the conversion of β-D-galactose to α-D-galactose by the enzyme, mutarotase (GALM). The Leloir pathway then carries out the conversion of α-D-galactose to UDP-glucose via three principle enzymes. Galactokinase (GALK) phosphorylates α-D-galactose to galactose-1-phosphate, or Gal-1-P. Galactose-1-phosphate uridyltransferase (GALT) then transfers a UMP group from UDP-glucose to Gal-1-P to form UDP-galactose. Finally, UDP galactose-4’-epimerase (GALE) interconverts UDP-galactose and UDP-glucose, thereby completing the pathway.[7]

However, those suffering from galactosemia cannot properly break down galactose as the result of a genetically inherited mutation in one of the enzymes in the Leloir pathway. These individuals cannot break down galactose properly, so the consumption of even small amounts of galactose is harmful to galactosemics.[8]


Galactose is found in dairy products, sugar beets, other gums and mucilages. It is also synthesized by the body, where it forms part of glycolipids and glycoproteins in several tissues; and is a by-product from the third-generation ethanol production process (from macroalgae).

Clinical significance

Chronic systemic exposure of mice, rats, and Drosophila to D-galactose causes the acceleration of senescence (aging) and has been used as an aging model.[9] Two studies have suggested a possible link between galactose in milk and ovarian cancer.[10][11] Other studies show no correlation, even in the presence of defective galactose metabolism.[12][13] More recently, pooled analysis done by the Harvard School of Public Health showed no specific correlation between lactose-containing foods and ovarian cancer, and showed statistically insignificant increases in risk for consumption of lactose at ≥30 g/d.[14] More research is necessary to ascertain possible risks.

Some ongoing studies suggest galactose may have a role in treatment of focal segmental glomerulosclerosis (a kidney disease resulting in kidney failure and proteinuria).[15] This effect is likely to be a result of binding of galactose to FSGS factor.[16]

Galactose is a component of the antigens present on blood cells that determine blood type within the ABO blood group system. In O and A antigens, there are two monomers of galactose on the antigens, whereas in the B antigens there are three monomers of glucose.[17]

Alpha-1,3-galactose, or Alpha-Gal for short, has been recognised as a delayed allergy to mammal meat, affecting a growing number of the population. This allergy is initially caused by a tick bite. An Alpha-Gal Allergy Awareness (AGAA) team has been formed to help educate the public and increase awareness about this allergy in the food service industry.[18]


In 1855, E. O. Erdmann noted that hydrolysis of lactose produced a substance besides glucose.[19] Galactose was first isolated and studied by Louis Pasteur in 1856.[20] He called it "lactose".[21] In 1860, Berthelot renamed it "galactose" or "glucose lactique".[22][23] In 1894, Emil Fischer and Robert Morrell determined the configuration of galactose.[24]

See also


  1. ^ a b Ophardt, C. Galactose
  2. ^ Nassau et al. Galactofuranose Biosynthesis in Escherichia coli K-12:... JOURNAL OF BACTERIOLOGY, Feb. 1996, p. 1047–1052
  3. ^ Staff (June 2009). "Lactose Intolerance - National Digestive Diseases Information Clearinghouse". Retrieved January 11, 2014. 
  4. ^ Sunehag A, Tigas S, Haymond MW (January 2003). "Contribution of plasma galactose and glucose to milk lactose synthesis during galactose ingestion". J. Clin. Endocrinol. Metab. 88 (1): 225–9.  
  5. ^ Sunehag AL, Louie K, Bier JL, Tigas S, Haymond MW (January 2002). "Hexoneogenesis in the human breast during lactation". J. Clin. Endocrinol. Metab. 87 (1): 297–301.  
  6. ^ Fridovich-Keil JL, Walter JH. "Galactosemia". The Online Metabolic and Molecular Bases of Inherited Disease. 
    a 4 b 21 c 22 d 22
  7. ^ Bosch AM (August 2006). "Classical galactosaemia revisited". J. Inherit. Metab. Dis. 29 (4): 516–25.  
    a 517 b 516 c 519
  8. ^ Elsas, L. I. . Galactosemia
  9. ^ Cui, X.; Zuo, P.; Zhang, Q.; Li, X.; Hu, Y.; Long, J.; Packer, L.; Liu, J. (2006). "Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid". Journal of neuroscience research 84 (3): 647–654.  
  10. ^ Cramer D (1989). "Lactase persistence and milk consumption as determinants of ovarian cancer risk". Am J Epidemiol 130 (5): 904–10.  
  11. ^ Cramer D, Harlow B, Willett W, Welch W, Bell D, Scully R, Ng W, Knapp R (1989). "Galactose consumption and metabolism in relation to the risk of ovarian cancer". Lancet 2 (8654): 66–71.  
  12. ^ Marc T. Goodman, Anna H. Wu, Ko-Hui Tung, Katharine McDuffie, Daniel W. Cramer, Lynne R. Wilkens, Keith Terada, Juergen K. V. Reichardt, and Won G. Ng (2002). "Association of Galactose-1-Phosphate Uridyltransferase Activity and N314D Genotype with the Risk of Ovarian Cancer". Am. J. Epidemiol 156 (8): 693–701.  
  13. ^ Fung, W. L. Alan, Risch, Harvey, McLaughlin, John, Rosen, Barry, Cole, David, Vesprini, Danny, Narod, Steven A. (2003). "The N314D Polymorphism of Galactose-1-Phosphate Uridyl Transferase Does Not Modify the Risk of Ovarian Cancer". Cancer Epidemiol Biomarkers Prev 12 (7): 678–80.  
  14. ^ Genkinger, Jeanine M., Hunter, David J., Spiegelman, Donna, Anderson, Kristin E., Arslan, Alan, Beeson, W. Lawrence, Buring, Julie E., Fraser, Gary E., Freudenheim, Jo L., Goldbohm, R. Alexandra, Hankinson, Susan E., Jacobs, David R., Jr., Koushik, Anita, Lacey, James V., Jr., Larsson, Susanna C., Leitzmann, Michael, McCullough, Marji L., Miller, Anthony B., Rodriguez, Carmen, Rohan, Thomas E., Schouten, Leo J., Shore, Roy, Smit, Ellen, Wolk, Alicja, Zhang, Shumin M., Smith-Warner, Stephanie A. (2006). "Dairy Products and Ovarian Cancer: A Pooled Analysis of 12 Cohort Studies". Cancer Epidemiol Biomarkers Prev 15 (2): 364–372.  
  15. ^ [1]
  16. ^ [2]
  17. ^ Peter H. Raven & George B. Johnson (1995). Carol J. Mills (ed), ed. Understanding Biology (3rd ed.). WM C. Brown. p. 203.  
  18. ^ AGAA, AGAA Home page.
  19. ^ See:
    • Eduard Otto Erdmann (1855) Dissertation: Dissertatio de saccharo lactico et amylaceo [Dissertation on milk sugar and starch](University of Berlin).
    • Jahresbericht über die Fortschritte der reinen, pharmaceutischen und technischen Chemie, … [Annual report on progress in pure, pharmaceutical, and technical chemistry, … ] (1855), pages 671-673; see especially p. 673.
  20. ^ Pasteur (1856) "Note sur le sucre de lait" (Note on milk sugar), Comptes rendus, 42 : 347-351.
  21. ^ Pasteur (1856), p. 348. From page 348: "Je propose de le nommer lactose." (I propose to name it lactose.)
  22. ^ Marcellin Berthelot, Chimie organique fondée sur la synthèse [Organic chemistry based on synthesis] (Paris, France: Mallet-Bachelier, 1860), vol. 2, pp. 248-249.
  23. ^ "Galactose" — from the Ancient Greek γάλακτος (gálaktos, “milk”). See: Wiktionary: galactose.
  24. ^ Emil Fischer and Robert S. Morrell (1894) "Ueber die Configuration der Rhamnose und Galactose" (On the configuration of rhamnose and galactose), Berichte der Deutschen chemischen Gesellschaft zu Berlin, 27 : 382-394. The configuration of galactose appears on page 385.
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.